Stock Spotlight Archives - Page 175 of 379

WednesdayJun 23, 2021 2:14 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Setting Stage for Strengthened Demand for Blue Light Cystoscopy

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is working closely with manufacturing partner Lighthouse Imaging on its proprietary i/Blue Imaging System(TM) and is on target to conduct private demonstrations at the annual American Urology Association meeting set for early September. “The updated product design will incorporate changes intended to meet critical verification requirements established through benchmark testing of competitive systems and feedback from preliminary meetings with the FDA,” reads a recent article. “The additional testing and specification development focused on the contrast agent-induced fluorescence and the ability to replicate the clinical observations in bench-level settings. The sensitivity of the system can…

TuesdayJun 22, 2021 2:53 pm

QualityStocksNewsBreaks – Mobius Interactive Ltd. Levels Up to Enhance Player Experience

Mobius Interactive, an online esports and gaming operator, is leading with its esports product to take full advantage of the rapidly expanding global entertainment market. The global esports segment is on pace to nearly double its audience over the next six years to hit 646 million in 2023. As the audience grows, Mobius has leveled up to provide an engaging experience. “Mobius Interactive is committed to creating the ideal customer experience, using real-time CRM systems to ensure the entire player journey is optimized for entertainment,” reads a recent article. “Throughout its three diverse brands Mobius.bet, Club Double and Aragon Casino,…

TuesdayJun 22, 2021 2:42 pm

QualityStocksNewsBreaks – Why DSG Global Inc. (DSGT) Is ‘One to Watch’

DSG Global (OTCQB: DSGT) is an emerging global technology company with interconnecting businesses in rapidly growing market segments. A recent article discusses the company’s roots in the golf industry and move into road-ready electric vehicles for delivery in the third quarter of 2021. “In 2019, the company secured exclusive North America distribution rights for Jonway Automobile Co. road-ready electric vehicles (‘EVs’). Jonway, based in Zhejiang, China, began manufacturing new vehicles s in 2003 and today produces electric powered cars, trucks, vans, SUVs, and scooters. Jonway vehicles are exported to more than 80 countries and are built to comply with U.S.…

TuesdayJun 22, 2021 1:39 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Committed to Driving Novel Treatments Forward with Key Focus on Berubicin

CNS Pharmaceuticals’ (NASDAQ: CNSP) lead drug candidate, Berubicin, is a novel anthracycline, the first of which to appear capable of crossing the blood-brain barrier based on limited clinical data. The company is currently developing Berubicin in the treatment of several serious brain and central nervous system oncological indications. CNS is set to commence patient enrollment in a potentially pivotal study to evaluate the efficacy of Berubicin for adult glioblastoma multiforme (“GBM”) in the second quarter. Additionally, its sublicensee partner in Poland, WPD Pharmaceuticals, will initiate a Phase 2 multicenter clinical trial of Berubicin in adult GBM patients and is also…

TuesdayJun 22, 2021 1:18 pm

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advancing Rotigotine Development Program for Parkinson’s

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced its drug formulation and development, conducted primarily by its wholly owned German subsidiary, Vektor Pharma TF GmbH, are on schedule and continue to expand in scope. A recent article reads, “A Q1 trial announced in January 2021 and focusing on a human bioavailability pilot study of the Rotigotine transdermal patch for Parkinson’s Disease was completed in March 2021. Due to the favorable outcome of the study, the Rotigotine development program will be advanced to include a pivotal human trial.” The article, which documented XPhyto’s advancements so…

MondayJun 21, 2021 1:57 pm

QualityStocksNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) on Mission to ‘Deliver the Finest Genetics to Canadians’

Pac Roots (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian company dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, is committed to quality and excellence, as evidenced by its mantra: quality over quantity. “Pac Roots is focused on elite genetics development and maximizes the quality of its offerings by keeping yields and profit margins high,” reads a recent article. “The company also leverages key partnerships to ensure the superiority of its products. ‘Our mission is to deliver the finest genetics to Canadians,’ the company states. ‘Preserving the excellence of our elite strains while introducing the highest…

MondayJun 21, 2021 1:44 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) Partnering to Improve Standard of Care, Provide Turnkey Solutions in Plant-Based Medicine

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is working with doctors as well as government and university research centers to reduce the variations in treatment plans and trials. The company, which has developed and uses dose-measuring internet-of-things (“IoT”) devices to collect HIPPA-compliant data to improve future medical treatments, is guided by the need to transform patient care. Key to this focus is utilizing big data and AI to reshape how the world understands plant-based medicine. A recent article reads, “RYAH partners with doctors to improve the standard of care for patients and researchers to…

MondayJun 21, 2021 12:21 pm

QualityStocksNewsBreaks – Hero Technologies Inc. (HENC) Eyes over $1B in Revenue at End of Multiphase Plan

Hero Technologies (OTC: HENC), a cannabis company working toward a vertically integrated business model, is paying close attention to Michigan’s medicinal and recreational cannabis sales numbers, which are reaching record highs. This is because its majority-owned subsidiary, BlackBox Systems and Technologies LLC, earlier this year signed a purchase agreement to acquire 120 acres of Michigan farmland for cannabis cultivation. According to HENC CEO Gina Serkasevich, who was quoted in a recent article, the numbers for the company’s cannabis cultivation plan in Michigan, which it anticipates will take anywhere from five to ten years to complete, look exceptionally strong. “We have…

MondayJun 21, 2021 12:06 pm

QualityStocksNewsBreaks – Why Golden Triangle Ventures Inc. (GTVH) Is ‘One to Watch’

Golden Triangle Ventures (OTC: GTVH) (“GTV”), a multifaceted company that currently wholly owns four subsidiaries — Global Health Services, Lavish Entertainment (EpicRaves), HyFrontier Technologies, and Napa Wine Brands — is committed to purchasing, acquiring and/or partnering with promising established entities. Through the guidance of the management team, comprising of Steffan Dalsgaard, GTV’s founder and executive chairman; GTV’s chief innovations officer and director and the CEO of HyFrontier, Robert Dubose; and Stuart Seim, GTV’s chief development officer and director, the company has made notable strides towards the fulfillment of this goal. “On May 26, 2021, Golden Triangle announced its acquisition of…

MondayJun 21, 2021 11:26 am

QualityStocksNewsBreaks – Brain Scientific Inc. (BRSF) Revolutionizing Portable EEG Diagnostics Space

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in contact sports are usually minor; however, some can lead to significant long-term cognitive, physical and psychosocial impairments. “Unfortunately,” observes a recent article, “at this moment, it is challenging to differentiate between the two.” CT is the most commonly used imaging procedure but is not effective when conducting a post-concussion examination. MRIs and neuropsychologic testing are somewhat more effective but are…

Site Search

Company Search

Category: Stock Spotlight